Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 108 articles:
HTML format
Text format



Single Articles


    March 2017
  1. YUAN Z, Shi X, Qiu Y, Jia T, et al
    Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin.
    Oncol Rep. 2017;37:1815-1825.
    PubMed     Text format     Abstract available


    January 2017
  2. SAETANG J, Sangkhathat S
    Diets link metabolic syndrome and colorectal cancer development (Review).
    Oncol Rep. 2017 Jan 18. doi: 10.3892/or.2017.5385.
    PubMed     Text format     Abstract available


  3. CHEN Y, Zhang Y, He J, Fu Y, et al
    MicroRNA-133b is regulated by TAp63 while no gene mutation is present in colorectal cancer.
    Oncol Rep. 2017 Jan 16. doi: 10.3892/or.2017.5371.
    PubMed     Text format     Abstract available


  4. WANG H, Chen Z, Chang H, Mu X, et al
    Expression of glia maturation factor gamma is associated with colorectal cancer metastasis and its downregulation suppresses colorectal cancer cell migration and invasion in vitro.
    Oncol Rep. 2017 Jan 9. doi: 10.3892/or.2017.5361.
    PubMed     Text format     Abstract available


  5. JANOWSKI E, Timofeeva O, Chasovskikh S, Goldberg M, et al
    Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies.
    Oncol Rep. 2017;37:57-65.
    PubMed     Text format     Abstract available


  6. HUANG G, Chen X, Cai Y, Wang X, et al
    miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer.
    Oncol Rep. 2017;37:571-578.
    PubMed     Text format     Abstract available


    December 2016
  7. FUJIYOSHI K, Yamamoto G, Takahashi A, Arai Y, et al
    High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5323.
    PubMed     Text format     Abstract available


  8. WANG T, Ning K, Lu TX, Hua D, et al
    Elevated expression of TrpC5 and GLUT1 is associated with chemoresistance in colorectal cancer.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5322.
    PubMed     Text format     Abstract available


  9. ZHANG C, Gong P, Liu P, Zhou N, et al
    Thioridazine elicits potent antitumor effects in colorectal cancer stem cells.
    Oncol Rep. 2016 Dec 14. doi: 10.3892/or.2016.5313.
    PubMed     Text format     Abstract available


    November 2016
  10. KIJIMA T, Hazama S, Tsunedomi R, Tanaka H, et al
    MicroRNA-6826 and -6875 in plasma are valuable noninvasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer.
    Oncol Rep. 2016 Nov 22. doi: 10.3892/or.2016.5267.
    PubMed     Text format     Abstract available


  11. MIYO M, Konno M, Colvin H, Nishida N, et al
    The importance of mitochondrial folate enzymes in human colorectal cancer.
    Oncol Rep. 2016 Nov 22. doi: 10.3892/or.2016.5264.
    PubMed     Text format     Abstract available


  12. FU Q, Cheng J, Zhang J, Zhang Y, et al
    miR-20b reduces 5-FU resistance by suppressing the ADAM9/EGFR signaling pathway in colon cancer.
    Oncol Rep. 2016 Nov 18. doi: 10.3892/or.2016.5259.
    PubMed     Text format     Abstract available


  13. JIANG D, Wang L, Zhao T, Zhang Z, et al
    Restoration of the tumor-suppressor function to mutant p53 by Ganoderma lucidum polysaccharides in colorectal cancer cells.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5246.
    PubMed     Text format     Abstract available


  14. WEN W, Liu G, Jin K, Hu X, et al
    TGF-beta1 induces PGP9.5 expression in CAFs to promote the growth of colorectal cancer cells.
    Oncol Rep. 2016 Nov 9. doi: 10.3892/or.2016.5238.
    PubMed     Text format     Abstract available


  15. ZHAO M, Yu Z, Li Z, Tang J, et al
    Expression of angiogenic growth factors VEGF, bFGF and ANG1 in colon cancer after bevacizumab treatment in vitro: A potential self-regulating mechanism.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5231.
    PubMed     Text format     Abstract available


  16. LIU N, Li J, Zhao Z, Han J, et al
    MicroRNA-302a enhances 5-fluorouracil-induced cell death in human colon cancer cells.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5237.
    PubMed     Text format     Abstract available


  17. ONOZAWA H, Saito M, Saito K, Kanke Y, et al
    Annexin A1 is involved in resistance to 5-FU in colon cancer cells.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5234.
    PubMed     Text format     Abstract available


  18. ZHAO J, Lv Y, Cai Y, Wei W, et al
    Hyperthermic carbon dioxide pneumoperitoneum reinforces the inhibition of 5-FU on the proliferation and invasion of colon cancer.
    Oncol Rep. 2016 Nov 8. doi: 10.3892/or.2016.5229.
    PubMed     Text format     Abstract available


  19. HUANG HL, Chen WC, Hsu HP, Cho CY, et al
    Silencing of argininosuccinate lyase inhibits colorectal cancer formation.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5221.
    PubMed     Text format     Abstract available


  20. KIM DH, Kim MJ, Sung B, Suh H, et al
    Resveratrol analogue, HS-1793, induces apoptotic cell death and cell cycle arrest through downregulation of AKT in human colon cancer cells.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5219.
    PubMed     Text format     Abstract available


  21. LEE CY, Hsieh SL, Hsieh S, Tsai CC, et al
    Inhibition of human colorectal cancer metastasis by notoginsenoside R1, an important compound from Panax notoginseng.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5222.
    PubMed     Text format     Abstract available


  22. GAO L, Zhou Y, Zhou SX, Yu XJ, et al
    PLD4 promotes M1 macrophages to perform antitumor effects in colon cancer cells.
    Oncol Rep. 2016 Nov 3. doi: 10.3892/or.2016.5216.
    PubMed     Text format     Abstract available


    October 2016
  23. SUZUKI N, Nakagawa F, Matsuoka K, Takechi T, et al
    Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5208.
    PubMed     Text format     Abstract available


  24. WU H, Cheng X, Ji X, He Y, et al
    Cortactin contributes to the tumorigenicity of colorectal cancer by promoting cell proliferation.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5207.
    PubMed     Text format     Abstract available


  25. RIFFO-CAMPOS AL, Castillo J, Vallet-Sanchez A, Ayala G, et al
    In silico RNA-seq and experimental analyses reveal the differential expression and splicing of EPDR1 and ZNF518B genes in relation to KRAS mutations in colorectal cancer cells.
    Oncol Rep. 2016 Oct 27. doi: 10.3892/or.2016.5210.
    PubMed     Text format     Abstract available


  26. TAKATSUNA M, Morohashi S, Yoshizawa T, Hirai H, et al
    Myofibroblast distribution is associated with invasive growth types of colorectal cancer.
    Oncol Rep. 2016 Oct 25. doi: 10.3892/or.2016.5202.
    PubMed     Text format     Abstract available


  27. FU Q, Cheng J, Zhang J, Zhang Y, et al
    Downregulation of YEATS4 by miR-218 sensitizes colorectal cancer cells to L-OHP-induced cell apoptosis by inhibiting cytoprotective autophagy.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5195.
    PubMed     Text format     Abstract available


  28. WANG L, Yu P
    miR-300 promotes proliferation and EMT-mediated colorectal cancer migration and invasion by targeting p53.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5193.
    PubMed     Text format     Abstract available


  29. ZHANG Y, Yuan J, Zhang X, Yan F, et al
    Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway.
    Oncol Rep. 2016 Oct 21. doi: 10.3892/or.2016.5194.
    PubMed     Text format     Abstract available


  30. LIN J, Feng J, Jin Y, Yan Z, et al
    Pien Tze Huang suppresses VEGF-C-mediated lymphangiogenesis in colorectal cancer.
    Oncol Rep. 2016 Oct 20. doi: 10.3892/or.2016.5186.
    PubMed     Text format     Abstract available


  31. MARLICZ W, Sielatycka K, Serwin K, Kubis E, et al
    Effect of colorectal cancer on the number of normal stem cells circulating in peripheral blood.
    Oncol Rep. 2016 Oct 18. doi: 10.3892/or.2016.5179.
    PubMed     Text format     Abstract available


  32. ZHOU X, Wang P, Zhang YJ, Xu JJ, et al
    Comparative proteomic analysis of melanosis coli with colon cancer.
    Oncol Rep. 2016 Oct 17. doi: 10.3892/or.2016.5178.
    PubMed     Text format     Abstract available


  33. YI W, Xiao E, Ding R, Luo P, et al
    High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-kappaB/p53-apoptosis signaling pathway in colorectal cancer.
    Oncol Rep. 2016 Oct 17. doi: 10.3892/or.2016.5177.
    PubMed     Text format     Abstract available


  34. ZHANG H, Qiao L, Li X, Wan Y, et al
    Tissue metabolic profiling of lymph node metastasis of colorectal cancer assessed by 1H NMR.
    Oncol Rep. 2016 Oct 14. doi: 10.3892/or.2016.5175.
    PubMed     Text format     Abstract available


    September 2016
  35. FAN XJ, Wang Y, Wang L, Zhu M, et al
    Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway.
    Oncol Rep. 2016 Sep 30. doi: 10.3892/or.2016.5138.
    PubMed     Text format     Abstract available


  36. HOLZNER S, Senfter D, Stadler S, Staribacher A, et al
    Colorectal cancer cell-derived microRNA200 modulates the resistance of adjacent blood endothelial barriers in vitro.
    Oncol Rep. 2016 Sep 20. doi: 10.3892/or.2016.5114.
    PubMed     Text format     Abstract available


  37. HUANG C, Liu H, Gong XL, Wu L, et al
    Expression of DNA methyltransferases and target microRNAs in human tissue samples related to sporadic colorectal cancer.
    Oncol Rep. 2016 Sep 19. doi: 10.3892/or.2016.5104.
    PubMed     Text format     Abstract available


  38. YOO HI, Kim BK, Yoon SK
    MicroRNA-330-5p negatively regulates ITGA5 expression in human colorectal cancer.
    Oncol Rep. 2016 Sep 15. doi: 10.3892/or.2016.5092.
    PubMed     Text format     Abstract available


  39. KIM BR, Kang MH, Kim JL, Na YJ, et al
    RUNX3 inhibits the metastasis and angiogenesis of colorectal cancer.
    Oncol Rep. 2016 Sep 12. doi: 10.3892/or.2016.5086.
    PubMed     Text format     Abstract available


    August 2016
  40. JING X, Wu H, Ji X, Wu H, et al
    Cortactin promotes cell migration and invasion through upregulation of the dedicator of cytokinesis 1 expression in human colorectal cancer.
    Oncol Rep. 2016 Aug 31. doi: 10.3892/or.2016.5058.
    PubMed     Text format     Abstract available


  41. LI S, Wu X, Xu Y, Wu S, et al
    miR-145 suppresses colorectal cancer cell migration and invasion by targeting an ETS-related gene.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5042.
    PubMed     Text format     Abstract available


  42. WU Y, Xie R, Liu X, Wang J, et al
    Knockdown of FOXK1 alone or in combination with apoptosis-inducing 5-FU inhibits cell growth in colorectal cancer.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5041.
    PubMed     Text format     Abstract available


  43. ZHANG SS, Huang ZW, Li LX, Fu JJ, et al
    Identification of CD200+ colorectal cancer stem cells and their gene expression profile.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5039.
    PubMed     Text format     Abstract available


  44. RUWAN KUMARA MH, Piao MJ, Kang KA, Ryu YS, et al
    Non-thermal gas plasma-induced endoplasmic reticulum stress mediates apoptosis in human colon cancer cells.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5038.
    PubMed     Text format     Abstract available


  45. ACQUAVIVA R, Sorrenti V, Santangelo R, Cardile V, et al
    Effects of an extract of Celtis aetnensis (Tornab.) Strobl twigs on human colon cancer cell cultures.
    Oncol Rep. 2016 Aug 24. doi: 10.3892/or.2016.5035.
    PubMed     Text format     Abstract available


  46. XIONG W, Gao D, Li Y, Liu X, et al
    Genome-wide profiling of chemoradiationinduced changes in alternative splicing in colon cancer cells.
    Oncol Rep. 2016 Aug 12. doi: 10.3892/or.2016.5022.
    PubMed     Text format     Abstract available


  47. OKADA K, Hakata S, Terashima J, Gamou T, et al
    Combination of the histone deacetylase inhibitor depsipeptide and 5-fluorouracil upregulates major histocompatibility complex class II and p21 genes and activates caspase-3/7 in human colon cancer HCT-116 cells.
    Oncol Rep. 2016 Aug 8. doi: 10.3892/or.2016.5008.
    PubMed     Text format     Abstract available


    July 2016
  48. XU K, Wang J, Gao J, Di J, et al
    GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer.
    Oncol Rep. 2016 Jul 21. doi: 10.3892/or.2016.4961.
    PubMed     Text format     Abstract available


  49. XU W, Xu B, Yao Y, Yu X, et al
    RNA interference against TRIM29 inhibits migration and invasion of colorectal cancer cells.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4941.
    PubMed     Text format     Abstract available


  50. WEI H, Cheng Z, Ouyang C, Zhang Y, et al
    Glycoprotein screening in colorectal cancer based on differentially expressed Tn antigen.
    Oncol Rep. 2016 Jul 14. doi: 10.3892/or.2016.4937.
    PubMed     Text format     Abstract available


  51. TAKATSUNA M, Morohashi S, Yoshizawa T, Hirai H, et al
    Myofibroblasts of the muscle layer stimulate the malignant potential of colorectal cancer.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4932.
    PubMed     Text format     Abstract available


  52. ZHU L, Tian G, Yang Q, De G, et al
    Thyroid hormone receptor beta1 suppresses proliferation and migration by inhibiting PI3K/Akt signaling in human colorectal cancer cells.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4931.
    PubMed     Text format     Abstract available


  53. LIANG L, Huang J
    Oxymatrine inhibits epithelial-mesenchymal transition through regulation of NF-kappaB signaling in colorectal cancer cells.
    Oncol Rep. 2016 Jul 11. doi: 10.3892/or.2016.4927.
    PubMed     Text format     Abstract available


    June 2016
  54. IWAI T, Sugimoto M, Harada S, Yorozu K, et al
    Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model.
    Oncol Rep. 2016 Jun 22. doi: 10.3892/or.2016.4902.
    PubMed     Text format     Abstract available


  55. KIM EH, Lee H, Jeong YK, Jung WG, et al
    Mechanisms of SU5416, an inhibitor of vascular endothelial growth factor receptor, as a radiosensitizer for colon cancer cells.
    Oncol Rep. 2016 Jun 10. doi: 10.3892/or.2016.4868.
    PubMed     Text format     Abstract available


    May 2016
  56. KANG HR, Choi HG, Jeon CK, Lim SJ, et al
    Butyrate-mediated acquisition of chemoresistance by human colon cancer cells.
    Oncol Rep. 2016 May 27. doi: 10.3892/or.2016.4838.
    PubMed     Text format     Abstract available


  57. CUI F, Wang S, Lao I, Zhou C, et al
    miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes.
    Oncol Rep. 2016 May 24. doi: 10.3892/or.2016.4834.
    PubMed     Text format     Abstract available


  58. LEE MH, Hong SH, Park C, Kim GY, et al
    Hwang-Heuk-San induces apoptosis in HCT116 human colorectal cancer cells through the ROS-mediated activation of caspases and the inactivation of the PI3K/Akt signaling pathway.
    Oncol Rep. 2016 May 17. doi: 10.3892/or.2016.4812.
    PubMed     Text format     Abstract available


  59. HAN J, Liu Z, Wang N, Pan W, et al
    MicroRNA-874 inhibits growth, induces apoptosis and reverses chemoresistance in colorectal cancer by targeting X-linked inhibitor of apoptosis protein.
    Oncol Rep. 2016 May 16. doi: 10.3892/or.2016.4810.
    PubMed     Text format     Abstract available


  60. ZHA H, Sun H, Li X, Duan L, et al
    S100A8 facilitates the migration of colorectal cancer cells through regulating macrophages in the inflammatory microenvironment.
    Oncol Rep. 2016 May 6. doi: 10.3892/or.2016.4790.
    PubMed     Text format     Abstract available


  61. SHOJI H, Motegi M, Osawa K, Okonogi N, et al
    Radiofrequency thermal treatment with chemoradiotherapy for advanced rectal cancer.
    Oncol Rep. 2016;35:2569-75.
    PubMed     Text format     Abstract available


    April 2016
  62. WU QX, Yuan SX, Ren CM, Yu Y, et al
    Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells.
    Oncol Rep. 2016 Apr 7. doi: 10.3892/or.2016.4735.
    PubMed     Text format     Abstract available


  63. PONNUSAMY S, Lattmann E, Lattmann P, Thiyagarajan T, et al
    Novel, isoform-selective, cholecystokinin A receptor antagonist inhibits colon and pancreatic cancers in preclinical models through novel mechanism of action.
    Oncol Rep. 2016;35:2097-106.
    PubMed     Text format     Abstract available


    March 2016
  64. KIM N, Cho SB, Park YL, Park SY, et al
    Effect of Recepteur d'Origine Nantais expression on chemosensitivity and tumor cell behavior in colorectal cancer.
    Oncol Rep. 2016 Mar 31. doi: 10.3892/or.2016.4721.
    PubMed     Text format     Abstract available


  65. HUANG G, Cheng J, Yu F, Liu X, et al
    Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.
    Oncol Rep. 2016 Mar 17. doi: 10.3892/or.2016.4685.
    PubMed     Text format     Abstract available


  66. ZHANG Z, Chen H, Xu C, Song L, et al
    Curcumin inhibits tumor epithelialmesenchymal transition by downregulating the Wnt signaling pathway and upregulating NKD2 expression in colon cancer cells.
    Oncol Rep. 2016 Mar 10. doi: 10.3892/or.2016.4669.
    PubMed     Text format     Abstract available


  67. LI J, Wang SW, Zhang DS, Sun Y, et al
    FTY720-induced enhancement of autophagy protects cells from FTY720 cytotoxicity in colorectal cancer.
    Oncol Rep. 2016 Mar 9. doi: 10.3892/or.2016.4668.
    PubMed     Text format     Abstract available


  68. REN CM, Li Y, Chen QZ, Zeng YH, et al
    Oridonin inhibits the proliferation of human colon cancer cells by upregulating BMP7 to activate p38 MAPK.
    Oncol Rep. 2016 Mar 7. doi: 10.3892/or.2016.4654.
    PubMed     Text format     Abstract available


  69. KIM A, Im M, Ma JY
    Sosihotang ameliorates cachexiarelated symptoms in mice bearing colon 26 adenocarcinoma by reducing systemic inflammation and muscle loss.
    Oncol Rep. 2016;35:1841-50.
    PubMed     Text format     Abstract available


    February 2016
  70. BI DP, Yin CH, Zhang XY, Yang NN, et al
    miR-183 functions as an oncogene by targeting ABCA1 in colon cancer.
    Oncol Rep. 2016 Feb 23. doi: 10.3892/or.2016.4631.
    PubMed     Text format     Abstract available


  71. QU H, Yin H, Yan S, Tao M, et al
    Inhibitor of growth 4 suppresses colorectal cancer growth and invasion by inducing G1 arrest, inhibiting tumor angiogenesis and reversing epithelial-mesenchymal transition.
    Oncol Rep. 2016 Feb 18. doi: 10.3892/or.2016.4626.
    PubMed     Text format     Abstract available


  72. TSENG A, Yang CH, Chen CH, Chen CH, et al
    An in vivo molecular response analysis of colorectal cancer treated with Astragalus membranaceus extract.
    Oncol Rep. 2016;35:659-668.
    PubMed     Text format     Abstract available


  73. XIANG T, Yu F, Fei R, Qian J, et al
    CHRNA7 inhibits cell invasion and metastasis of LoVo human colorectal cancer cells through PI3K/Akt signaling.
    Oncol Rep. 2016;35:999-1005.
    PubMed     Text format     Abstract available


  74. ZHAO D, Sui Y, Zheng X
    miR-331-3p inhibits proliferation and promotes apoptosis by targeting HER2 through the PI3K/Akt and ERK1/2 pathways in colorectal cancer.
    Oncol Rep. 2016;35:1075-1082.
    PubMed     Text format     Abstract available


  75. JIA Y, Zhang S, Miao L, Wang J, et al
    [Corrigendum] Activation of platelet protease-activated receptor-1 induces epithelial-mesenchymal transition and chemotaxis of colon cancer cell line SW620.
    Oncol Rep. 2016;35:1222.
    PubMed     Text format     Abstract available


  76. ZHAO J, Cai Y, Yin C, Lv Y, et al
    Study on the inhibition of hyperthermic CO2 pneumoperitoneum on the proliferation and migration of colon cancer cells and its mechanism.
    Oncol Rep. 2016;35:985-991.
    PubMed     Text format     Abstract available


  77. YOUSEF BA, Guerram M, Hassan HM, Hamdi AM, et al
    Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins.
    Oncol Rep. 2016;35:1091-1100.
    PubMed     Text format     Abstract available


  78. HUANG W, Liu Z, Zhou G, Tian A, et al
    Magnetic gold nanoparticle-mediated small interference RNA silencing Bag-1 gene for colon cancer therapy.
    Oncol Rep. 2016;35:978-984.
    PubMed     Text format     Abstract available


  79. LUO J, Xu L, Jiang Y, Zhuo D, et al
    Expression profile of long non-coding RNAs in colorectal cancer: A microarray analysis.
    Oncol Rep. 2016 Feb 1. doi: 10.3892/or.2016.4606.
    PubMed     Text format     Abstract available


  80. YORIFUJI N, Inoue T, Iguchi M, Fujiwara K, et al
    The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice.
    Oncol Rep. 2016;35:676-82.
    PubMed     Text format     Abstract available


    January 2016
  81. ZHENG YM, Lu AX, Shen JZ, Kwok AH, et al
    Imperatorin exhibits anticancer activities in human colon cancer cells via the caspase cascade.
    Oncol Rep. 2016 Jan 21. doi: 10.3892/or.2016.4586.
    PubMed     Text format     Abstract available


  82. LI Z, Wang H, Xu Z, Sun Y, et al
    Expression and mechanism of microRNA-181A on incidence and survival in late liver metastases of colorectal cancer.
    Oncol Rep. 2016 Jan 5. doi: 10.3892/or.2016.4546.
    PubMed     Text format     Abstract available


  83. KASAI C, Sugimoto K, Moritani I, Tanaka J, et al
    Comparison of human gut microbiota in control subjects and patients with colorectal carcinoma in adenoma: Terminal restriction fragment length polymorphism and next-generation sequencing analyses.
    Oncol Rep. 2016;35:325-33.
    PubMed     Text format     Abstract available


  84. WENG WH, Leung WH, Pang YJ, Hsu HH, et al
    Lauric acid can improve the sensitization of Cetuximab in KRAS/BRAF mutated colorectal cancer cells by retrievable microRNA-378 expression.
    Oncol Rep. 2016;35:107-16.
    PubMed     Text format     Abstract available


    December 2015
  85. WU R, Chen Y, Li F, Li W, et al
    Effects of CD73 on human colorectal cancer cell growth in vivo and in vitro.
    Oncol Rep. 2015 Dec 23. doi: 10.3892/or.2015.4512.
    PubMed     Text format     Abstract available


  86. CHE XH, Chen CL, Ye XL, Weng GB, et al
    Dual inhibition of COX-2/5-LOX blocks colon cancer proliferation, migration and invasion in vitro.
    Oncol Rep. 2015 Dec 22. doi: 10.3892/or.2015.4506.
    PubMed     Text format     Abstract available


  87. LI J, Teng Y, Liu S, Wang Z, et al
    Cinnamaldehyde affects the biological behavior of human colorectal cancer cells and induces apoptosis via inhibition of the PI3K/Akt signaling pathway.
    Oncol Rep. 2015 Dec 17. doi: 10.3892/or.2015.4493.
    PubMed     Text format     Abstract available


  88. AL-KHAYAL K, Abdulla M, Al-Obeed O, Al Kattan W, et al
    Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients.
    Oncol Rep. 2015 Dec 17. doi: 10.3892/or.2015.4494.
    PubMed     Text format     Abstract available


  89. IHARA K, Yamaguchi S, Ueno N, Tani Y, et al
    Expression of DNA double-strand break repair proteins predicts the response and prognosis of colorectal cancer patients undergoing oxaliplatin-based chemotherapy.
    Oncol Rep. 2015 Dec 16. doi: 10.3892/or.2015.4488.
    PubMed     Text format     Abstract available


  90. MARQUEZ J, Mena J, Hernandez-Unzueta I, Benedicto A, et al
    Ocoxin(R) oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice.
    Oncol Rep. 2015 Dec 16. doi: 10.3892/or.2015.4486.
    PubMed     Text format     Abstract available


  91. QIAN K, Zhang J, Lu J, Liu W, et al
    FAM172A modulates apoptosis and proliferation of colon cancer cells via STAT1 binding to its promoter.
    Oncol Rep. 2015 Dec 10. doi: 10.3892/or.2015.4485.
    PubMed     Text format     Abstract available


  92. YANG Y, Luo H, Hui K, Ci Y, et al
    Selenite-induced autophagy antagonizes apoptosis in colorectal cancer cells in vitro and in vivo.
    Oncol Rep. 2015 Dec 10. doi: 10.3892/or.2015.4484.
    PubMed     Text format     Abstract available


  93. ZHANG B, Leng C, Wu C, Zhang Z, et al
    Smad4 sensitizes colorectal cancer to 5-fluorouracil through cell cycle arrest by inhibiting the PI3K/Akt/CDC2/survivin cascade.
    Oncol Rep. 2015 Dec 8. doi: 10.3892/or.2015.4479.
    PubMed     Text format     Abstract available


    November 2015
  94. YUAN SX, Wang DX, Wu QX, Ren CM, et al
    BMP9/p38 MAPK is essential for the antiproliferative effect of resveratrol on human colon cancer.
    Oncol Rep. 2015 Nov 10. doi: 10.3892/or.2015.4407.
    PubMed     Text format     Abstract available


  95. YANG XD, Xu HT, Xu XH, Ru G, et al
    Knockdown of long non-coding RNA HOTAIR inhibits proliferation and invasiveness and improves radiosensitivity in colorectal cancer.
    Oncol Rep. 2015 Nov 4. doi: 10.3892/or.2015.4397.
    PubMed     Text format     Abstract available


  96. QI F, Wei L, Shen A, Chen Y, et al
    Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway.
    Oncol Rep. 2015 Nov 2. doi: 10.3892/or.2015.4378.
    PubMed     Text format     Abstract available


    October 2015
  97. YANG L, Qiu M, Xu Y, Wang J, et al
    Upregulation of long non-coding RNA PRNCR1 in colorectal cancer promotes cell proliferation and cell cycle progression.
    Oncol Rep. 2015 Oct 30. doi: 10.3892/or.2015.4364.
    PubMed     Text format     Abstract available


  98. XIANG T, Fei R, Wang Z, Shen Z, et al
    Nicotine enhances invasion and metastasis of human colorectal cancer cells through the nicotinic acetylcholine receptor downstream p38 MAPK signaling pathway.
    Oncol Rep. 2015 Oct 30. doi: 10.3892/or.2015.4363.
    PubMed     Text format     Abstract available


  99. DU C, Wang X, Zhang J, Liu X, et al
    Paxillin is positively correlated with the clinicopathological factors of colorectal cancer, and knockdown of Paxillin improves sensitivity to cetuximab in colorectal cancer cells.
    Oncol Rep. 2015 Oct 27. doi: 10.3892/or.2015.4352.
    PubMed     Text format     Abstract available


    August 2015
  100. FANG H, Kang J, Du R, Zhao X, et al
    Growth inhibitory effect of adenovirus-mediated tissue-targeted expression of ribosomal protein L23 on human colorectal carcinoma cells.
    Oncol Rep. 2015;34:763-70.
    PubMed     Text format     Abstract available


    July 2015
  101. KIM JS, Son Y, Bae MJ, Lee M, et al
    Administration of granulocyte colony-stimulating factor with radiotherapy promotes tumor growth by stimulating vascularization in tumor-bearing mice.
    Oncol Rep. 2015;34:147-54.
    PubMed     Text format     Abstract available


    June 2015
  102. ATSUMI J, Hanami T, Enokida Y, Ogawa H, et al
    Eprobe-mediated screening system for somatic mutations in the KRAS locus.
    Oncol Rep. 2015;33:2719-27.
    PubMed     Text format     Abstract available


    May 2015
  103. JI M, Lee EJ, Kim KB, Kim Y, et al
    HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
    Oncol Rep. 2015;33:2299-308.
    PubMed     Text format     Abstract available


    April 2015
  104. INOUE T, Yorifuji N, Iguchi M, Fujiwara K, et al
    Geranylgeranylacetone suppresses colitisrelated mouse colon carcinogenesis.
    Oncol Rep. 2015;33:1769-74.
    PubMed     Text format     Abstract available


  105. HASHIMI SM, Xu T, Wei MQ
    Violacein anticancer activity is enhanced under hypoxia.
    Oncol Rep. 2015;33:1731-6.
    PubMed     Text format     Abstract available


  106. SONG J, Liu H, Li Z, Yang C, et al
    Cucurbitacin I inhibits cell migration and invasion and enhances chemosensitivity in colon cancer.
    Oncol Rep. 2015;33:1867-71.
    PubMed     Text format     Abstract available


    March 2015
  107. JIKIHARA H, Qi G, Nozoe K, Hirokawa M, et al
    Aged garlic extract inhibits 1,2-dimethylhydrazine-induced colon tumor development by suppressing cell proliferation.
    Oncol Rep. 2015;33:1131-40.
    PubMed     Text format     Abstract available


  108. XIANG S, Fang J, Wang S, Deng B, et al
    MicroRNA135b regulates the stability of PTEN and promotes glycolysis by targeting USP13 in human colorectal cancers.
    Oncol Rep. 2015;33:1342-8.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: